In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering ...

TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Grove Biopharma has raised a $30 million series A round to develop Bionic Biologics, also known as protein-like polymers (PLP ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

Peptides are essentially proteins in your skin. Some hypotheses suggest they stimulate collagen and lead to skin regeneration. Get the details here.

Ascletis's news arrives shortly after Eli Lilly reported favourable Phase III weight loss data for its oral GLP-1RA, ...

The AI and machine learning technology of Renova Health, which comprises natural language processing (NLP) and a large language model (LLM) platform, provides TNF with the capabil ...

Corxel Pharmaceuticals has received investigational new drug (IND) application clearance from the US Food and Drug Administration (FDA) for the randomised US Phase II trial of oral small molecule ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

A federal judge stopped the Trump administration on Monday from rescinding deportation protections and work permits for more than a half-million Cubans, Haitians, Nicaraguans and Venezuelans who were ...